Rare diseases
Investigational molecules
Locations
Back to Italy2 862 clinical trials in Saronno, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Effectiveness and Safety of CYP-001 and Corticosteroids for Adults with High-Risk Acute Graft Versus Host Disease
ItalyStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
ItalyStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
ItalyStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
ItalyStudy of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer
ItalyStudy of Olaparib and Abiraterone for Men with Advanced Prostate Cancer Resistant to Hormone Therapy
ItalyStudy on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy
ItalyStudy on the Safety of CRD-4730 for Patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
ItalyStudy on Durvalumab and Chemotherapy for Patients with Advanced Biliary Tract Cancer
ItalyStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
ItalyStudy on the Safety and Effectiveness of 2-Hydroxyoleic Acid and Temozolomide with Radiotherapy for Patients with Newly Diagnosed Glioblastoma
ItalyStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including studies evaluating novel therapeutic approaches for patients with specific genetic mutations.
Research emphasizes personalized treatment strategies for advanced and metastatic disease states.
Comprehensive studies addressing breast cancer and gynecological malignancies, with focus on treatment timing and maintenance therapies.
Investigations aim to optimize treatment sequences and improve patient outcomes.
Innovative research in renal cell carcinoma treatment and cardiac conditions, particularly focusing on novel therapeutic approaches.
Studies evaluate both oncological interventions and cardiovascular treatments for high-risk patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
